A more definitive study on Avandia’s risks is in jeopardy as patients are starting to drop out:
Dr. Krall said he did not yet know how many patients have withdrawn, but said Glaxo was now worried about whether it could complete the drug trial, which has been scheduled to run through next year. The company has been counting on a successful outcome from the study to dispel widespread concerns that Avandia carries a higher risk of heart attacks than other diabetes drugs.
Related posts:
- Does Avandia cause heart attacks, and why the RECORD study is important
- Avandia: The RECORD study
- Steven Nissen was wrong about Avandia
- Avandia, MI, and cardiac death
- Avandia and heart attacks
- "Should I keep taking Avandia?"
- 5 diabetes posts you may have missed
KevinMD.com on Facebook
Comments on this entry are closed.